Injectables

See Also:

Family Health International's work in Africa, Asia, and Latin America has included both research and interventions related to use of injectable contraceptives. We have trained clinicians and community-based distribution workers in method provision, researched method acceptability among both users and providers, explored reasons for method discontinuation, and evaluated method introduction into family planning programs. 

Injectable contraceptives are popular because they require only periodic visits to a health-care provider, are highly effective, can be used without a partner's knowledge, and do not interfere with sex. Combined injectable contraceptives contain the hormones estrogen and progestin. They are administered by intramuscular injection once a month.   Progestin-only injectable contraceptives (e.g., Depo Provera/DMPA, Noristerat) contain no estrogen. To prevent pregnancy, a shot is given every two or three months, depending on the type of injectable.  

Selected Publications   

Family Health Research: Improving Access to Family Planning (2007, Vo. 1, Issue 2)

Mechanisms of the Contraceptive Action of Hormonal Methods and Intrauterine Devices (IUDs)

Improving Access to Family Planning: Community-based Distribution of DMPA

Network: Chronic Diseases and Contraceptive Use
(1999, Volume 19, Number 2)


Training Materials

Checklists for Clients who Want to Initiate DMPA (or NET-EN)

Using Contraceptive Checklists in Community-Based Programs: Pills and Injectables (2003)

Contraceptive Technology and Reproductive Health Series Training Modules: Injectable Contraceptives

DMPA Provision by Community-Based Reproductive Health Workers in Africa (2007, PDF, 695 KB)